Skip to content

Clinical trials

Bone Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Neoplasms Country / region: China Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20171
20183
20192
20212
20221
20233
20245
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status7
Not yet recruiting4
Recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University People's Hospital3
Second Affiliated Hospital, Zhejiang University, School of Medicine3
Peking University Third Hospital2
Shanghai Yunying Medical Technology2
Shenzhen Geno-Immune Medical Institute2
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1
First Affiliated Hospital of Fujian Medical University1
Genor Biopharma Co., Ltd.1
Guangdong Provincial People's Hospital1
Henan Cancer Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Neoplasms22
Sarcoma6
Osteosarcoma4
Sarcoma, Ewing4
Spinal Cord Neoplasms2
Breast Neoplasms1
Infections1
Lymphoma1
Neoplasms1
Soft Tissue Neoplasms1

Trials

Showing 76 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.